Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses

Sverre E. Kjeldsen, Gloria Cha, Giuseppe Villa, Giuseppe Mancia

Research output: Contribution to journalArticle

Abstract

DISTINCT was an 8-week, double-blind, randomized study to investigate the antihypertensive efficacy and safety of various nifedipine gastrointestinal treatment system (GITS)/candesartan cilexetil (N/C) dose combinations, vs respective monotherapies or placebo, in patients with diastolic blood pressure (DBP) ≥95 to

Original languageEnglish
JournalJournal of Clinical Pharmacology
DOIs
Publication statusAccepted/In press - 2016

    Fingerprint

Keywords

  • Candesartan cilexetil
  • Combination therapy
  • DISTINCT study
  • Essential hypertension
  • Nifedipine GITS
  • Vasodilatory side effects

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this